申请人:Hoelzemann Guenter
公开号:US20100234369A1
公开(公告)日:2010-09-16
Novel 5-cyanothienopyridines of the formula (I), in which R
1
, R
2
and R
3
have the meanings indicated in Claim
1
, are inhibitors of TGF-beta receptor kinase, and can be employed, inter alia, for the treatment of tumors.
公式为(I)的新型5-氰基噻吡啶化合物,其中R1、R2和R3的含义如权利要求1所述,是TGF-beta受体激酶的抑制剂,可用于治疗肿瘤等疾病。